Affordable Diabetes Drug Reduces Long-COVID Risk By 41 Percent: Study

Tyler Durden's Photo
by Tyler Durden
Tuesday, Jul 18, 2023 - 12:20 AM

Authored by Spring Lin via The Epoch Times (emphasis ours),

Is there a way to prevent long COVID? A new study in the United States found that taking metformin, an affordable first-line Type 2 diabetes drug, shortly after diagnosis of COVID-19 can reduce the risk of developing long COVID by about 41 percent.


The study was conducted by researchers from the University of Minnesota, and the paper was published in the international medical journal The Lancet Infectious Diseases in June.

Long COVID refers to persistent discomfort for weeks or months after being infected with COVID-19. Common symptoms include fatigue, shortness of breath, cognitive impairment, headache, chest pain, and joint pain, among others, which affect daily life.

Through remote recruitment, the researchers screened 1,126 participants who agreed to long-term follow-up. They were overweight and obese people aged 30 to 85, had symptoms of COVID-19 infection for fewer than seven days, tested positive for COVID within three days of trial enrollment, and had no previous known SARS-CoV-2 infection.

In this randomized trial, about half of the participants took metformin, and the other half took a placebo. They were also randomly assigned to receive either ivermectin, fluvoxamine, or placebo.

After 300 days of follow-up, 10.4 percent of participants who took the placebo were diagnosed with long COVID, while 6.3 percent who took metformin were also diagnosed.

The results of the study showed that taking metformin reduced the risk of developing long COVID by 41 percent. In subjects who took metformin within three days of symptom onset, the risk of developing long COVID was reduced by 63 percent.

The study also proved that taking metformin reduced the risk of developing long COVID in people infected during the peak period of the three SARS-CoV-2 variants, Alpha, Delta, and Omicron.

However, the study found that taking ivermectin or fluvoxamine showed no signs of protection against long COVID.

Metformin, originally developed from the French lilac (Galega officinalis), is inexpensive and has no significant side effects. For decades, it has been the drug of choice for Type 2 diabetes treatment worldwide.

Researchers believe metformin could be used as a therapeutic drug for outpatients infected with COVID-19. It has the merits of proven clinical efficacy, is available all over the world at a low cost, and is safe to use.

Read more here...